Marathi
|
Hindi
Download App
Epaper
Home
City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
City
Home
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Lok Sabha Election 2024
Heatwave In India
Mumbai Water Cut
Maharashtra Lok Sabha Election
IPL 2024
Salman Khan
All
News
Photos
Videos
Cipla
FOLLOW
Cipla, Latest News
Cipla Limited is an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.
Read More
National :
Cipla seeks DCGI nod for import of Moderna's COVID-19 vaccine: Sources
The Mumbai-based pharmaceutical multinational Cipla, on behalf of the US pharma major Moderna, has requested for import and marketing authorisation of its COVID-19 vaccines. ...
National :
Pfizer tells Centre its vaccine suitable for 12 years and above
American pharmaceutical giant Pfizer on Wednesday informs the Central government that its COVID-19 vaccine is suitable for all aged 12 and above and can be stored at 2-8 degrees for over a month, according to the sources. ...
International :
Pfizer to send 50 million COVID-19 vaccines to India with conditions
US pharmaceutical giant Pfizer is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday. ...
National :
COVID antibody cocktail used to treat Donald Trump now launched in India
Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose. ...
National :
COVID-19: Production capacity of Remdesivir increased to nearly 119 lakh vials per month, says Govt
With the sudden increase of cases during the second wave of the pandemic, the government has taken swift actions to enhance the availability of an anti-viral drug Remdesivir across the country. Presently, nearly 119 lakh vials of Remdesivir are being ...
Business :
Lilly signs pacts with Cipla, Lupin, Sun Pharma to accelerate availability of baricitinib for Covid-19 patients
US pharmaceutical major Eli Lilly said on Monday it has issued royalty-free, non-exclusive voluntary licenses to Cipla, Lupin and Sun Pharmaceutical to accelerate and expand the availability of baricitinib in India for Covid-19 patients. ...
Business :
Pharmaceutical market rebounds in March at 10.3 pc: Ind-Ra
India Ratings and Research (Ind-Ra) has said the 10.3 per cent year-on-year growth of India's pharmaceutical market during March was led by volume growth of 1.6 per cent, price growth of 5.1 per cent and products launches at 3.6 per cent. ...
National :
Indore faces shortage of Remdesivir, oxygen supplies
Madhya Pradesh's Indore is facing a shortage of Remdesivir injection and oxygen supplies due to an increase in Covid-19 cases. ...
Previous Page
Next Page